Gianluigi De Renzi
Rome, 00161, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Circulating Cancer-Associated Macrophage-like Cells as a Blood-Based Biomarker of Response to Immune Checkpoint Inhibitors.
Journal: International journal of molecular sciences
Published: February 19, 2024
Early Detection of Disease Progression in Metastatic Cancers: Could CTCs Improve RECIST Criteria?
Journal: Biomedicines
Published: January 04, 2024
Prognostic Role of Circulating Tumor Cell Trajectories in Metastatic Colorectal Cancer.
Journal: Cells
Published: March 02, 2023
Genomic landscape and survival analysis of ctDNA "neo-RAS wild-type" patients with originally RAS mutant metastatic colorectal cancer.
Journal: Frontiers in oncology
Published: February 07, 2023
In vitro cultures of circulating tumor cells: a potential tool to unravel drug sensitivity.
Journal: Cancer drug resistance (Alhambra, Calif.)
Published: November 15, 2021
Comparison of Two Blood-Based Genotyping Tests to Investigate the KRAS G12C Mutation in Patients with Non-Small-Cell Lung Cancer at Failure of First-Line Treatments.
Journal: Diagnostics (Basel, Switzerland)
Published: October 08, 2021
True conversions from RAS mutant to RAS wild-type in circulating tumor DNA from metastatic colorectal cancer patients as assessed by methylation and mutational signature.
Journal: Cancer letters
Published: February 03, 2021
Circulating Methylated DNA to Monitor the Dynamics of RAS Mutation Clearance in Plasma from Metastatic Colorectal Cancer Patients.
Journal: Cancers
Published: November 20, 2020
Showing 1-11 of 11
Last Updated: 09/26/2026